Bonato Cassiane, Severino Romulo França, Elnecave Regina Helena
Endocrinology Division, Hospital de Clinicas de Porto Alegre, Brazil.
J Pediatr Endocrinol Metab. 2008 Oct;21(10):943-9. doi: 10.1515/jpem.2008.21.10.943.
Children treated for cancer may have sequelae due to the treatment. The aim of this study was to assess the frequency of hypothyroidism and the thyroid volume of patients treated with radiotherapy for cancer during childhood.
Fifty-nine patients treated with external beam radiation to different areas of the body during childhood.
Cross-sectional study of patients assessed for late effects of external beam radiation treatment for childhood cancer. General and anthropometric characteristics, time from radiotherapy, family history of thyroid dysfunction, radiotherapy report, thyroid function tests, antithyroperoxidase antibodies and thyroid ultrasound were analyzed.
Hypothyroidism was found in 23 (39%) patients, 3.5 +/- 1.9 years after radiotherapy carried out at the mean age of 7.6 +/- 3.4 years. Site of irradiation had the greatest association with hypothyroidism. Anti-thyroperoxidase antibodies were normal in all patients. Thyroid volume was significantly lower in irradiated patients with hypothyroidism than in those with normal thyroid function (p <0.001).
Hypothyroidism is very common in survivors of childhood cancer treated with external beam radiation. Primary thyroid damage is suggested because of the smaller thyroid volume.
接受癌症治疗的儿童可能因治疗而出现后遗症。本研究的目的是评估儿童期接受癌症放射治疗的患者甲状腺功能减退的发生率以及甲状腺体积。
59例在儿童期接受身体不同部位外照射治疗的患者。
对接受儿童癌症外照射治疗远期效应评估的患者进行横断面研究。分析了一般和人体测量特征、放疗后的时间、甲状腺功能障碍家族史、放疗报告、甲状腺功能测试、抗甲状腺过氧化物酶抗体和甲状腺超声检查结果。
在平均年龄7.6±3.4岁时接受放疗,放疗后3.5±1.9年,23例(39%)患者出现甲状腺功能减退。照射部位与甲状腺功能减退的关联最为密切。所有患者的抗甲状腺过氧化物酶抗体均正常。甲状腺功能减退的受照射患者的甲状腺体积明显低于甲状腺功能正常的患者(p<0.001)。
接受外照射治疗的儿童癌症幸存者中甲状腺功能减退非常常见。由于甲状腺体积较小,提示存在原发性甲状腺损伤。